The article cites a research study by Michael C. Sneller et al. describing a therapeutic vaccine regimen in HIV-infected individuals in whom antiretroviral therapy was started during the early stage of HIV infection. The randomized, placebo-controlled trial was conducted to determine whether the vaccine was safe and could induce an immune response.